KRISTIN HARRIS: Open Payments
NPI 1871935882 · BEVERLY HILLS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$714 in 30 payments from 14 companies in 2025. Trend: 2023 $584 · 2024 $632 · 2025 $714
Food & beverage: $714
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $198 |
| GENZYME CORPORATION | 2 | $94 |
| Galderma Laboratories, L.P. | 2 | $64 |
| Novartis Pharmaceuticals Corporation | 2 | $59 |
| UCB, Inc. | 2 | $50 |
| Lilly USA, LLC | 2 | $44 |
| Botanix SB Inc | 2 | $38 |
| Arcutis Biotherapeutics, Inc. | 2 | $34 |
| Regeneron Healthcare Solutions, Inc. | 1 | $32 |
| LEO Pharma Inc. | 1 | $23 |
Products named: SKYRIZI, DUPIXENT, NEMLUVIO, Rhapsido, Bimzelx, TALTZ, RINVOQ, SOFDRA.
Industry payments across CA — which companies pay providers there.
